Latest Regulatory Approvals News

The Supreme Court of New South Wales has approved the acquisition scheme for Donaco International by On Nut Road Limited, setting the stage for share suspension and final payment in August 2025.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

Dundee Precious Metals has secured the Bosnian Competition Council's approval, clearing a major regulatory hurdle in its planned acquisition of Adriatic Metals. The deal now moves closer to completion pending shareholder and court approvals.

Silex Systems Limited has announced a $145 million equity raise to fund the commercialisation of its SILEX laser uranium enrichment technology through its US joint venture, Global Laser Enrichment. The capital will support critical technology milestones and expansion into new isotope markets amid a global nuclear fuel renaissance.

Silex Systems has raised $130 million through an institutional placement to advance its SILEX uranium enrichment technology in the US, bolstering its financial position through FY2028.

Atomo Diagnostics has secured a US$410,000 order from Lumos Diagnostics for its Pascal test cassettes, following Lumos's exclusive six-year US distribution deal for the FebriDx test with PHASE Scientific.

Energy Transition Minerals Ltd (ETM) has won the bid for the Penouta mine in Spain, the EU’s sole tin-tantalum-niobium producer, raising A$10 million to support the acquisition and development amid regulatory hurdles.

Light & Wonder reported solid Q2 earnings growth and margin expansion despite slight revenue dip, completed Grover acquisition ahead of schedule, and announced plans to delist from Nasdaq for a sole ASX listing by November 2025.

Locksley Resources has completed an oversubscribed capital raising and appointed Tribeca Capital to drive its U.S.-focused critical minerals strategy, targeting rare earths and antimony supply chains aligned with government initiatives.

Toys"R"Us ANZ has formalised a Deed of Company Arrangement, paving the way for Directed Electronics Australia to acquire the company and trigger its delisting from the ASX.

Silk Logistics Holdings has secured court approval for its acquisition by DP World Australia, with shares set to be suspended on the ASX and a cash payout scheduled for shareholders.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.